Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:940-944
Published online before print March 13, 2003, doi: 10.1161/01.ATV.0000066878.27340.22
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/6/940    most recent
01.ATV.0000066878.27340.22v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, Y.-J.
Right arrow Articles by Bar-Shavit, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, Y.-J.
Right arrow Articles by Bar-Shavit, R.
Related Collections
Right arrow Angiogenesis
Right arrow Pathophysiology
Right arrow Thrombin
Right arrow Signal transduction
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:940.)
© 2003 American Heart Association, Inc.


ATVB in Focus

Human Protease-Activated Receptor 1 Expression in Malignant Epithelia

A Role in Invasiveness

Yong-Jun Yin; Zaidoun Salah; Sorina Grisaru-Granovsky; Irit Cohen; Sharona Cohen Even-Ram; Myriam Maoz; Beatrice Uziely; Tamar Peretz; Rachel Bar-Shavit

From the Department of Oncology Hadassah-University Hospital, Jerusalem, Israel.

Correspondence to Rachel Bar-Shavit, PhD, Department of Oncology, Hadassah-University Hospital, POB 12000, Jerusalem 91120, Israel. E-mail barshav{at}md.huji.ac.il

Series Editor: Marschall S. Runge
ATVB In Focus Extracellular Mediators in Atherosclerosis and Thrombosis

Previous Brief Reviews in this Series:

•Brasier AR, Recinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. 2002;22:1257–1266.
•Moser M, Patterson C. Thrombin and vascular development: a sticky subject. 2003;23:922–930.
•Major CD, Santulli RJ, Derian CK, Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. 2003;23:931–939.

While protease-activated receptors (PARs) play a traditional role in vascular biology, they emerge with surprisingly new assignments in tumor biology. PAR1 expression correlates with the invasion properties of breast carcinoma, whereas human PAR1 antisense reduces their ability to migrate through Matrigel. Part of the molecular mechanism of PAR1 invasion involves the formation of focal contact complexes on PAR1 activation. PAR1 induces angiogenesis in animal models in vivo and exhibits an oncogenic phenotype of enhanced ductal complexity when overexpressed in mouse mammary glands.


Key Words: PAR1 • epithelia • invasion • metastasis • angiogenesis




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. H. Versteeg, F. Schaffner, M. Kerver, L. G. Ellies, P. Andrade-Gordon, B. M. Mueller, and W. Ruf
Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice
Cancer Res., September 1, 2008; 68(17): 7219 - 7227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Salah, M. Maoz, G. Pizov, and R. Bar-Shavit
Transcriptional Regulation of Human Protease-Activated Receptor 1: A Role for the Early Growth Response-1 Protein in Prostate Cancer
Cancer Res., October 15, 2007; 67(20): 9835 - 9843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Arciniegas, M. G. Frid, I. S. Douglas, and K. R. Stenmark
Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L1 - L8.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Arora, T. K. Ricks, and J. Trejo
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer
J. Cell Sci., March 15, 2007; 120(6): 921 - 928.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Z. Salah, M. Maoz, E. Pokroy, M. Lotem, R. Bar-Shavit, and B. Uziely
Protease-Activated Receptor-1 (hPar1), A Survival Factor Eliciting Tumor Progression
Mol. Cancer Res., March 1, 2007; 5(3): 229 - 240.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Goerge, A. Barg, E.-M. Schnaeker, B. Poppelmann, V. Shpacovitch, A. Rattenholl, C. Maaser, T. A. Luger, M. Steinhoff, and S. W. Schneider
Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.
Cancer Res., August 1, 2006; 66(15): 7766 - 7774.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-J. Yin, V. Katz, Z. Salah, M. Maoz, I. Cohen, B. Uziely, H. Turm, S. Grisaru-Granovsky, H. Suzuki, and R. Bar-Shavit
Mammary Gland Tissue Targeted Overexpression of Human Protease-Activated Receptor 1 Reveals a Novel Link to {beta}-Catenin Stabilization.
Cancer Res., May 15, 2006; 66(10): 5224 - 5233.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Belting, J. Ahamed, and W. Ruf
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1545 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, M. D. Hollenberg, and J. L. Wallace
Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets
PNAS, January 4, 2005; 102(1): 216 - 220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ahamed and W. Ruf
Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic Domain
J. Biol. Chem., May 28, 2004; 279(22): 23038 - 23044.
[Abstract] [Full Text] [PDF]